Priyanka Rani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Priyanka Rani has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Dilipkumar Pal
Department of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (Central University), Bilaspur, India
3 shared publicationsSyed Riaz Hashim
Department of Chemistry, School of Pharmaceutical Sciences, IFTM University Moradabad, Moradabad, India
3 shared publications- Rahul Rama Hegde
C Department of Pharmaceutics , School of Pharmaceutical Sciences, IFTM University Moradabad , Uttar Pradesh , India
2 shared publications Rahul Rama Hegde
Department of Pharmaceutics, School of Pharmaceutical Sciences, IFTM University Moradabad, Moradabad, India
1 shared publication
Latest Publications
- 23 October 2021
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 55 (7) , 715-723
New Mercaptoacetamide Derivatives: Synthesis and Assessment as Antimicrobial and Antimycobacterial Agents
- 23 October 2021
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 55 (7) , 715-723
New Mercaptoacetamide Derivatives: Synthesis and Assessment as Antimicrobial and Antimycobacterial Agents
- 3 July 2016
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 28 (4) , 255-265
Acetamides: chemotherapeutic agents for inflammation-associated cancers
Now clear evidences are available to support the hypothesis that inflammation accelerates the conditions including events and molecules that reach to various types of cancers. Inflammation is a normal response to infection containing the innate and adaptive immune systems. However, when allowed to continue, unresolved, perturbation of cellular microenvironment takes place; therefore, it leads to adaptations in genes that are linked to cancer. In addition, a lot of data are accessible confirming the concept that tumour microenvironment is orchestrated by various inflammatory cells and goes to neoplastic process and finally invasion, migration and metastasis. However, infiltrations of leucocytes lead to angiogenesis, propagation and invasion. An inflammatory microenvironment that perhaps fostering impact of angiogenesis include cytokines, chemokines, enzymes and growth factors that play key role for expansion and invasion of cancer cells. This insight highlights the pathogenesis of inflammation-associated cancers and also touches and fosters the role of acetamides for the treatment and chemoprevention of carcinomas that are allied with inflammation.
- 3 July 2016
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 28 (4) , 255-265
Acetamides: chemotherapeutic agents for inflammation-associated cancers
Now clear evidences are available to support the hypothesis that inflammation accelerates the conditions including events and molecules that reach to various types of cancers. Inflammation is a normal response to infection containing the innate and adaptive immune systems. However, when allowed to continue, unresolved, perturbation of cellular microenvironment takes place; therefore, it leads to adaptations in genes that are linked to cancer. In addition, a lot of data are accessible confirming the concept that tumour microenvironment is orchestrated by various inflammatory cells and goes to neoplastic process and finally invasion, migration and metastasis. However, infiltrations of leucocytes lead to angiogenesis, propagation and invasion. An inflammatory microenvironment that perhaps fostering impact of angiogenesis include cytokines, chemokines, enzymes and growth factors that play key role for expansion and invasion of cancer cells. This insight highlights the pathogenesis of inflammation-associated cancers and also touches and fosters the role of acetamides for the treatment and chemoprevention of carcinomas that are allied with inflammation.
- 19 May 2016
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (999) , 1
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives
- 19 May 2016
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 16 (999) , 1
Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives